Abstract:Peptide drugs are increasingly used to treat a variety of diseases ranging from cancer, and infections to cardiovascular diseases. However, peptides can suffer from low stability in the bloodstream. Entrapment of peptides into nano-sized carriers of various types has widely been explored, but all of them have spherical shapes. Nanocellulose can in contrast serve as a non-spherical nanoparticle with a high aspect ratio. After the isolation of nanocellulose by TEMPO-mediated oxidation, the material needs to be modified with polymers to generate nanoparticles with high water-solubility that can also favourably interact with peptide drugs. We have here chosen insulin as the model drug, which can strongly interact with cationic polymers. As it is known that cationic polymer may retain charged drugs too tightly, we have selected poly(2-(dimethylamino)ethyl acrylate) PDMAEA as a degradable polymer that undergoes self-hydrolysis to poly(acrylic acid) in water. This polymer was compared to poly(N-(3-(dimethylamino)propyl) acrylamide) PDMAPAA, which is a stable cationic polymer. The cationic polymer was co-grafted with poly(2-hydroxyethyl acrylate) PHEA as a water-soluble neutral polymer using the three-component Passerini reaction. A combination of fluorescence and UV-Vis techniques were used to quantify the amount of polymer that was conjugated to the surface. The polymer-coated nanocellulose was labelled with the fluorescent cyanine dye Cy5 while insulin was labelled with Cy3 creating a FRET system that allows monitoring of the interaction between insulin and polymer in cell growth media. We observed that despite the self-hydrolysis of PDMAEA into a negatively charged polymer, the negatively charged insulin was not released in buffer solution according to the FRET studies. Only the addition of serum-supplemented cell growth media led to insulin release. The limited release was explained with the fact that insulin, as well as other peptides, have a mixture of negative and positive charges, with the pH value and the isoelectric point determining the balance between both. Negative-charged polymers can therefore still interact favourably with negatively charged peptides by interacting with cationic amino acids.

Functionalized gold nanoparticle-polypyrrole nanobiocomposite with high effective surface area for electrochemical/pH dual stimuli-responsive smart release of insulin

Electrically controlled release of insulin using polypyrrole nanoparticles

pH and H2O2 dual-sensitive nanoparticles enable enhanced and safe glucose-responsive oral insulin delivery for diabetes mellitus treatment

Microneedle-array patch with pH-sensitive formulation for glucose-responsive insulin delivery

Preparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles

Functional Nanochaperones for PEGylated Insulin Delivery in Long-Term Glycemic Control

Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery

Drug Release from Electric-Field-Responsive Nanoparticles

pH-sensitive semi-interpenetrating network of microcrystalline cellulose and methacrylic acid hydrogel for the oral delivery of insulin

Oral delivery of insulin with intelligent glucose-responsive switch for blood glucose regulation

In Situ-Forming Protein-Polymer Hydrogel for Glucose-Responsive Insulin Release.

Construction of a graphene/polypyrrole composite electrode as an electrochemically controlled release system

Bioinspired Zwitterionic Polyphosphoester Modified Porous Silicon Nanoparticles For Efficient Oral Insulin Delivery

Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.

Bio-Inspired Synthetic Nanovesicles for Glucose-Responsive Release of Insulin

Polymer-Covalent Organic Frameworks Composites for Glucose and pH Dual-Responsive Insulin Delivery in Mice

A non-spherical nanoparticles system for the delivery of peptides using polymer grafted nanocellulose

Ligand-switchable nanoparticles resembling viral surface for sequential drug delivery and improved oral insulin therapy

pH-sensitive chitosan-deoxycholic acid/alginate nanoparticles for oral insulin delivery

Chitosan-Derived Nanocarrier Polymers for Drug Delivery and pH-Controlled Release in Type 2 Diabetes Treatment

Polypyrrole-Based Implantable Electroactive Pump For Controlled Drug Microinjection